Menzel Garry E (CIK 0001556064)

Latest company ownership

Shares held
1,121,604
Last filed at
Jul 1, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jul 10, 2023 Jul 10, 2023 Adaptimmune Therapeutics PLC Director Sell 46.3 -47,702 -38.86% ✗ $43.4K